- Home
- ZEPP vs CLNN Comparison
ZEPP vs CLNN Comparison
Compare ZEPP & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- CLNN
- Stock Information
- Founded
- ZEPP 2013
- CLNN 2012
- Country
- ZEPP China
- CLNN United States
- Employees
- ZEPP N/A
- CLNN N/A
- Industry
- ZEPP Computer Manufacturing
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- CLNN Health Care
- Exchange
- ZEPP Nasdaq
- CLNN Nasdaq
- Market Cap
- ZEPP 48.8M
- CLNN 43.0M
- IPO Year
- ZEPP N/A
- CLNN N/A
- Fundamental
- Price
- ZEPP $3.29
- CLNN $4.61
- Analyst Decision
- ZEPP
- CLNN Strong Buy
- Analyst Count
- ZEPP 0
- CLNN 4
- Target Price
- ZEPP N/A
- CLNN $59.25
- AVG Volume (30 Days)
- ZEPP 11.0K
- CLNN 53.4K
- Earning Date
- ZEPP 11-18-2024
- CLNN 11-13-2024
- Dividend Yield
- ZEPP N/A
- CLNN N/A
- EPS Growth
- ZEPP N/A
- CLNN N/A
- EPS
- ZEPP N/A
- CLNN N/A
- Revenue
- ZEPP $237,238,260.00
- CLNN $421,000.00
- Revenue This Year
- ZEPP N/A
- CLNN N/A
- Revenue Next Year
- ZEPP $18.83
- CLNN $1,058.37
- P/E Ratio
- ZEPP N/A
- CLNN N/A
- Revenue Growth
- ZEPP N/A
- CLNN N/A
- 52 Week Low
- ZEPP $2.06
- CLNN $3.82
- 52 Week High
- ZEPP $8.40
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- ZEPP 40.51
- CLNN 38.38
- Support Level
- ZEPP $3.00
- CLNN $4.65
- Resistance Level
- ZEPP $3.43
- CLNN $6.04
- Average True Range (ATR)
- ZEPP 0.19
- CLNN 0.48
- MACD
- ZEPP -0.02
- CLNN -0.14
- Stochastic Oscillator
- ZEPP 21.51
- CLNN 11.08
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).